AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.06
+0.38 (8.24%)
At close: Jul 2, 2026, 4:00 PM EDT
5.06
0.00 (0.10%)
After-hours: Jul 2, 2026, 6:10 PM EDT
AVITA Medical Revenue
AVITA Medical had revenue of $19.25M in the quarter ending March 31, 2026, with 3.98% growth. This brings the company's revenue in the last twelve months to $72.35M, up 0.96% year-over-year. In the year 2025, AVITA Medical had annual revenue of $71.61M with 11.45% growth.
Revenue (ttm)
$72.35M
Revenue Growth
+0.96%
P/S Ratio
2.15
Revenue / Employee
$320,119
Employees
226
Market Cap
155.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.61M | 7.36M | 11.45% |
| Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
| Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
| Dec 31, 2022 | 34.42M | 5.19M | 17.75% |
| Jun 30, 2021 | 29.23M | 14.97M | 104.95% |
| Jun 30, 2020 | 14.26M | 8.79M | 160.56% |
| Jun 30, 2019 | 5.47M | 4.55M | 489.24% |
| Jun 30, 2018 | 929.00K | 234.89K | 33.84% |
| Jun 30, 2017 | 694.11K | -52.35K | -7.01% |
| Jun 30, 2016 | 746.46K | -188.72K | -20.18% |
| Jun 30, 2015 | 935.18K | -2.16M | -69.75% |
| Jun 30, 2014 | 3.09M | -611.36K | -16.51% |
| Jun 30, 2013 | 3.70M | -1.59M | -30.06% |
| Jun 30, 2012 | 5.29M | 553.99K | 11.69% |
| Jun 30, 2011 | 4.74M | 1.45M | 44.21% |
| Jun 30, 2010 | 3.29M | 643.61K | 24.34% |
| Jun 30, 2009 | 2.64M | 768.38K | 40.97% |
| Jun 30, 2008 | 1.88M | 540.04K | 40.44% |
| Jun 30, 2007 | 1.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 351.50M |
| Quanterix | 144.98M |
| InfuSystem Holdings | 142.40M |
| RxSight | 127.48M |
| Owlet | 107.06M |
| CVRx, Inc. | 59.07M |
| Apyx Medical | 55.90M |
| MaxCyte | 32.29M |
RCEL News
- 4 days ago - Avita Medical price target raised to $12 from $5.50 at TD Cowen - TheFly
- 16 days ago - Avita Medical announces presentation of new clinical data on use of RECELL GO - TheFly
- 16 days ago - AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting - GlobeNewsWire
- 18 days ago - Avita Medical management to meet virtually with Lake Street - TheFly
- 6 weeks ago - AVITA Medical Transcript: Status update - Transcripts
- 6 weeks ago - AVITA Medical to Host Investor Webinar Briefing - GlobeNewsWire
- 7 weeks ago - Avita Medical upgraded to Buy from Hold at Lake Street - TheFly
- 7 weeks ago - Avita Medical reports Q1 EPS (35c), consensus (38c) - TheFly